// App-Quantinova.ai

: The primary aldosteronism rollercoaster: hypoaldosteronism as a potential postoperative complication

Researchers

Presenter

  • August Palma

Principal Investigators

  • Lihua Hu

  • Heok Cheow

  • Iosif Mendichovszky

  • Vasilis Kosmoliaptsis

  • Alison Marker

  • Waiel Bashari

  • Russell Senanayake

  • Mark Gurnell

Medical Centers

  • Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge Biomedical Campus, Cambridge, United Kingdom

  • University of Cambridge School of Clinical Medicine, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Nephrology

  • Endocrine/metabolic Diseases (ME)

Disease

  • Hypertension

  • Resistant hypertension

  • Primary aldosteronism

  • Orthostatic hypotension

  • Renal insufficiency

  • Hyperkalaemia

Biomarkers

  • Creatinine

  • Somatostatin

Drug/Treatment

  • Fludrocortisone

  • Eplerenone

  • Tetracosactide

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A